Development of CYP8B1-specific inhibitors for metabolic diseases.

Fang Z, Agua ARL, Jossart J, Sharma N, Lyu X, Wang Z, Zhang S, Sun J, Shi L, Ayard J, Chang M, Liu J, Kou K, Shively J, Garcia-Ocana A, Horne D, Yin H, Jin L, Perry JJP, Huang W

Open source

DOI
10.64898/2026.10.20.760253
Published
2026 Oct 21
Container
bioRxiv : the preprint server for biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.20.760253,
  title = {Development of CYP8B1-specific inhibitors for metabolic diseases.},
  author = {Fang Z and Agua ARL and Jossart J and Sharma N and Lyu X and Wang Z and Zhang S and Sun J and Shi L and Ayard J and Chang M and Liu J and Kou K and Shively J and Garcia-Ocana A and Horne D and Yin H and Jin L and Perry JJP and Huang W},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.10.20.760253},
  url = {https://doi.org/10.64898/2026.10.20.760253}
}

RIS

TY  - JOUR
TI  - Development of CYP8B1-specific inhibitors for metabolic diseases.
AU  - Fang Z
AU  - Agua ARL
AU  - Jossart J
AU  - Sharma N
AU  - Lyu X
AU  - Wang Z
AU  - Zhang S
AU  - Sun J
AU  - Shi L
AU  - Ayard J
AU  - Chang M
AU  - Liu J
AU  - Kou K
AU  - Shively J
AU  - Garcia-Ocana A
AU  - Horne D
AU  - Yin H
AU  - Jin L
AU  - Perry JJP
AU  - Huang W
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.10.20.760253
UR  - https://doi.org/10.64898/2026.10.20.760253
ER  - 

APA

Z, F., ARL, A., J, J., N, S., X, L., Z, W., S, Z., J, S., L, S., J, A., M, C., J, L., K, K., J, S., A, G., D, H., H, Y., L, J., JJP, P., & W, H. (2026). Development of CYP8B1-specific inhibitors for metabolic diseases.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.20.760253

Source records